Zacks: Analysts Anticipate Acadia Healthcare Company Inc (ACHC) Will Post Quarterly Sales of $763.10 Million

Share on StockTwits

Equities analysts forecast that Acadia Healthcare Company Inc (NASDAQ:ACHC) will announce $763.10 million in sales for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Acadia Healthcare’s earnings. The highest sales estimate is $773.69 million and the lowest is $755.00 million. Acadia Healthcare posted sales of $716.71 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 6.5%. The business is scheduled to announce its next quarterly earnings report after the market closes on Monday, November 5th.

According to Zacks, analysts expect that Acadia Healthcare will report full-year sales of $3.04 billion for the current fiscal year, with estimates ranging from $3.03 billion to $3.06 billion. For the next financial year, analysts anticipate that the company will post sales of $3.22 billion, with estimates ranging from $3.18 billion to $3.29 billion. Zacks’ sales averages are a mean average based on a survey of analysts that cover Acadia Healthcare.

ACHC has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 price objective on the stock in a research note on Tuesday, July 24th. ValuEngine upgraded Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research note on Thursday, July 26th. Credit Suisse Group lifted their price objective on Acadia Healthcare from $40.00 to $44.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 31st. Jefferies Financial Group lifted their price objective on Acadia Healthcare from $44.00 to $47.00 and gave the stock a “buy” rating in a research note on Tuesday, July 31st. Finally, BidaskClub lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, August 1st. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. Acadia Healthcare currently has an average rating of “Hold” and a consensus price target of $43.11.

Shares of Acadia Healthcare stock traded down $0.06 during trading on Tuesday, reaching $40.54. The company’s stock had a trading volume of 136,827 shares, compared to its average volume of 2,899,659. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.24 and a current ratio of 1.24. The firm has a market capitalization of $3.49 billion, a PE ratio of 17.77, a PEG ratio of 1.42 and a beta of 0.64. Acadia Healthcare has a one year low of $26.92 and a one year high of $45.02.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Teacher Retirement System of Texas boosted its holdings in Acadia Healthcare by 8.0% during the second quarter. Teacher Retirement System of Texas now owns 17,842 shares of the company’s stock valued at $730,000 after purchasing an additional 1,324 shares in the last quarter. People s United Financial Inc. boosted its holdings in Acadia Healthcare by 14.7% during the second quarter. People s United Financial Inc. now owns 10,549 shares of the company’s stock valued at $432,000 after purchasing an additional 1,350 shares in the last quarter. Amalgamated Bank boosted its holdings in Acadia Healthcare by 9.7% during the second quarter. Amalgamated Bank now owns 17,268 shares of the company’s stock valued at $706,000 after purchasing an additional 1,528 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in Acadia Healthcare by 10.2% during the third quarter. Oppenheimer Asset Management Inc. now owns 18,111 shares of the company’s stock valued at $638,000 after purchasing an additional 1,672 shares in the last quarter. Finally, Arizona State Retirement System boosted its holdings in Acadia Healthcare by 3.0% during the second quarter. Arizona State Retirement System now owns 56,971 shares of the company’s stock valued at $2,331,000 after purchasing an additional 1,679 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Recommended Story: Asset Allocation Models, Which is Right For You?

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply